The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4

Journal of Innate Immunity

Volumn 7, Issue , 2015, Pages 494-505

  Sheikh, Faruk ^a   Dickensheets, Harold ^a   Pedras Vasconcelos, Joao ^a   Ramalingam, Thirumalai ^b   Helming, Laura ^c   Gordon, Siamon ^d   Donnelly, Raymond P ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alternative macrophage activation; Arginase; Interleukin 13; Interleukin 13 receptor 1; Interleukin 4; STAT6

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4; STAT6 PROTEIN; ARG1 PROTEIN, MOUSE; ARGINASE; CD11 ANTIGEN; IL2RG PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR GAMMA; RETNLA PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE MARROW DERIVED MACROPHAGE; CELL FUSION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GIANT CELL; MACROPHAGE ACTIVATION; MEMBRANE FUSION; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; COMPLEMENT ALTERNATIVE PATHWAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM;

ANIMALS; ANTIGENS, CD11; ARGINASE; CELLS, CULTURED; COMPLEMENT PATHWAY, ALTERNATIVE; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; MACROPHAGES; MEMBRANE FUSION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; STAT6 TRANSCRIPTION FACTOR;

EID: 84941994059     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000376579     Document Type: Article

References (46)

1. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-? as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670-689.
2. Murray HW, Spitalny GL, Nathan CF: Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-?. J Immunol 1985; 134: 1619-1622.
3. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
4. Stein M, Keshav S, Harris N, Gordon S: Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287-292.
5. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassanzadeh Gh G: Differential expression of Fizz1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 2002; 71: 597-602.
6. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
7. van Dyken SJ, Locksley RM: Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013; 31: 317-343.
8. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, Wong SY, Gordon S, Brown GD: Dectin-1 expression and function are enhanced on alternatively activated and GMCSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol 2003; 171: 4569-4573.
9. Helming L, Gordon S: Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 2007; 37: 33-42.
10. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL: Modulation of murine macrophage function by IL-13. J Immunol 1993; 151: 7151-7160.
11. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-?. Eur J Immunol 1994; 24: 1441-1445.
12. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994; 265: 1701-1706.
13. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K, Paul WE, Ihle JN: Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995; 15: 3336-3343.
14. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL: Components of a STAT recognition code: evidence for two layers of molecular selectivity. Immunity 1995; 2: 689-697.
15. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J: Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995; 92: 3041-3050.
16. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630-633.
17. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signaling. Nature 1996; 380: 627-630.
18. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 1996; 157: 3220-3222.
19. Junttila IS, Mizukami K, Dickensheets H, Meier-Schellersheim M, Yamane H, Donnelly RP, Paul WE: Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4R?, IL-13R?1, and ?c regulates relative cytokine sensitivity. J Exp Med 2008; 205: 2595-2608.
20. Heller NM, Qi X, Junttila IS, Shirey KA, Vogel SN, Paul WE, Keegan AD: Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci Signal 2008; 1:ra17.
21. Sheikh F, Dickensheets H, Gamero AM, Vogel SN, Donnelly RP: An essential role for IFN-? in the induction of IFN-stimulated gene expression by LPS in macrophages. J Leukoc Biol 2014; 96: 591-600.
22. Noben-Trauth N, Shultz LD, Brombacher F, Urban JF Jr, Gu H, Paul WE: An interleukin 4 (IL-4)-independent pathway for CD4 + T cell IL-4 production is revealed in IL-4 receptordeficient mice. Proc Natl Acad Sci USA 1997; 94: 10838-10843.
23. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Katz SI, Love PE, Leonard WJ: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995; 2: 223-238.
24. Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS, Stevens S, Valenzuela DM, Murphy AJ, Yancopoulos GD, Urban JF Jr, Donnelly RP, Wynn TA: Unique functions of the type II interleukin-4 receptor identified in mice lacking the interleukin-13 receptor ?1 chain. Nat Immunol 2008; 9: 25-33.
25. Dickensheets HL, Venkataraman C, Schindler U, Donnelly RP: Interferons inhibit activation of STAT6 by interleukin-4 in human monocytes by inducing SOCS1 gene expression. Proc Natl Acad Sci USA 1999; 96: 10800-10805.
26. Ohmori Y, Smith MF Jr, Hamilton TA: IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 1996; 157: 2058-2065.
27. Pearse RN, Feinman R, Ravetch JV: Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by ?-interferon is mediated through common DNA response elements. Proc Natl Acad Sci USA 1991; 88: 11305-11309.
28. Dickensheets H, Vazquez N, Sheikh F, Gingras S, Murray PJ, Ryan JJ, Donnelly RP: Suppressor of cytokine signaling (SOCS)-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun 2007; 8: 21-27.
29. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2- C T method. Methods 2001; 25: 402-408.
30. Beckmann MP, Schooley KA, Gallis B, Vanden Bos T, Friend D, Alpert AR, Raunio R, Prickett KS, Baker PE, Park LS: Monoclonal antibodies block murine IL-4 receptor function. J Immunol 1990; 144: 4212-4217.
31. Hart PH, Bonder CS, Balogh J, Dickensheets HL, Vazquez N, Davies KV, Finlay-Jones JJ, Donnelly RP: Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13R-? 1 chain and STAT6. Eur J Immunol 1999; 29: 2087-2097.
32. Andersson A, Grunewald SM, Duschl A, Fischer A, DiSanto JP: Mouse macrophage development in the absence of the common ? chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur J Immunol 1997; 27: 1762-1768.
33. Schnyder B, Lugli S, Feng N, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, Moser R: Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 1996; 87: 4286-4295.
34. Kotowicz K, Callard RE, Friedrich K, Matthews DJ, Klein N: Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int Immunol 1996; 8: 1915-1925.
35. Munitz A, Brandt EB, Mingler M, Finkelman FD, Rothenberg ME: Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci USA 2008; 105: 7240-7245.
36. McInnes A, Rennick DM: Interleukin-4 induces cultured monocytes/macrophages to form giant multinucleated cells. J Exp Med 1988; 167: 598-611.
37. DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM: Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 1997; 158: 3385-3390.
38. Ohmori Y, Hamilton TA: IL-4-induced STAT6 suppresses IFN-?-stimulated STAT1-dependent transcription in mouse macrophages. J Immunol 1997; 159: 5474-5482.
39. Bogdan C, Thuring H, Dlaska M, Rollinghoff M, Weiss G: Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol 1997; 159: 4506-4513.
40. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC: Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008; 132: 259-272.
41. Ito T, Suzuki S, Kanaji S, Shiraishi H, Ohta S, Arima K, Tanaka G, Tamada T, Honjo E, Garcia KC, Kuroki R, Izuhara K: Distinct structural requirements for interleukin-4 (IL-4) and IL-13 binding to the shared IL-13 receptor facilitate cellular tuning of cytokine responsiveness. J Biol Chem 2009; 284: 24289-24296.
42. Song MM, Shuai K: The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 1998; 273: 35056-35062.
43. Brysha M, Zhang JG, Bertolino P, Corbin JE, Alexander WS, Nicola NA, Hilton DJ, Starr R: Suppressor of cytokine signaling-1 attenuates the duration of interferon ? signal transduction in vitro and in vivo. J Biol Chem 2001; 276: 22086-22089.
44. Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD: IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J Leukoc Biol 2007; 82: 1542-1553.
45. Helming L, Gordon S: Molecular mediators of macrophage fusion. Trends Cell Biol 2009; 19: 514-522.
46. Chang YJ, DeKruyff RH, Umetsu DT: The role of type 2 innate lymphoid cells in asthma. J Leukoc Biol 2013; 94: 933-940.